Oorsprong van het eerstegraads netwerk van Mark C. Clement
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 14 | |
Excalibur Fund Managers Ltd.
Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur Fund Managers Ltd (Excalibur) is a venture capital firm founded in 1996 by Christopher Evans. The firm is headquartered in London, United Kingdom.
2
| Subsidiary | Investment Managers | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Mark C. Clement via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
ACINO HOLDING AG | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
GRAUBÜNDNER KANTONALBANK | Regional Banks | Director/Board Member | |
BANK CLER AG | Regional Banks | Director/Board Member | |
Abbott GmbH (Germany)
Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Abbott GmbH & Co. KG develops and manufactures health care products. It is engaged in the discovery, development, manufacture, and marketing of pharmaceutical, diagnostic, nutritional, and hospital products. It offers pharmaceutical and diagnostic products ranging from prevention and diagnosis to treatment and cure. The company is headquartered in Ludwigshafen, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Knoll AG
Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The company is based in Haren, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bank Vontobel AG
Bank Vontobel AG Investment ManagersFinance Bank Vontobel AG (BV), formerly known as Bank J. Vontobel & Co AG, is a Zurich-based private bank. Established in 1924, BV is a wholly-owned subsidiary of Vontobel Holding AG (SW: VONN) and has offices in Geneva, New York, Frankfurt, Milan, Vienna and Luxembourg. The bank is VONN's private banking arm. In 2006 BV acquired the brokerage and corporate finance activities of Lombard Odier Darier Hentsch, which were integrated into their investment banking subsidiary, Vontobel Equity Research. BV specializes in financial consulting, research and wealth management via mutual funds, hedge funds, derivatives and special products for institutions, pension funds, corporates, high net-worth individuals, family offices and private individuals | Investment Managers | Corporate Officer/Principal | |
Boston University | College/University | Corporate Officer/Principal | |
University of Cambridge | College/University | Doctorate Degree | |
Princeton University | College/University | Corporate Officer/Principal Undergraduate Degree | |
University of Basel | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Director/Board Member Graduate Degree | |
University of Zurich | College/University | Graduate Degree | |
Heinrich-Heine-Universität Düsseldorf | College/University | Doctorate Degree | |
PricewaterhouseCoopers, Inc.
PricewaterhouseCoopers, Inc. Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers, Inc. is a South African company that provides accounting, auditing, and bookkeeping services. The company is based in Sunninghill, South Africa. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BASF Bioresearch Corp. | Corporate Officer/Principal | ||
ORASCOM DEVELOPMENT HOLDING AG | Homebuilding | Director/Board Member | |
SuppreMol GmbH
SuppreMol GmbH Pharmaceuticals: MajorHealth Technology SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
EVOLVA HOLDING SA | Food: Specialty/Candy | Director/Board Member | |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Pharmaceuticals: Major | Director/Board Member | |
North East Finance (Holdco) Ltd.
North East Finance (Holdco) Ltd. Financial ConglomeratesFinance North East Finance (Holdco) Ltd. operates as a holding fund manager. It is responsible for overseeing the delivery of the program. The company is headquartered in Newcastle-upon-Tyne, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
CFO Forum Schweiz | Corporate Officer/Principal | ||
Iksuda Therapeutics Ltd.
Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Biotechnology | Director/Board Member | |
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Pharmaceuticals: Generic | Chairman | |
BASF Pharma | President | ||
Pcovery ApS
Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman | |
Eternygen GmbH
Eternygen GmbH Pharmaceuticals: MajorHealth Technology Eternygen GmbH engages in the research and development of drugs. It develops new drugs for dietary-related metabolic diseases which include obesity, diabetes mellitus and fatty liver. The company was founded by Marco J. Janezic in June 2012 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chairman | |
Wyeth-lederle Pharma GmbH | Chief Executive Officer | ||
Minaris Regenerative Medicine GmbH
Minaris Regenerative Medicine GmbH BiotechnologyHealth Technology apceth Biopharma GmbH operates as a contract development & manufacturing organization. The firm specializes in cell-based and gene therapy products (Advanced Therapy Medicinal Products, ATMPs). Its GMP services include quality management, quality control, assay development, process development, cell banking & formulation and project management. The company was founded in 2007 and is headquartered in Munich, Germany. | Biotechnology | Director/Board Member | |
Inthera Bioscience AG
Inthera Bioscience AG BiotechnologyHealth Technology Inthera Bioscience AG engages in the research in as well as development, production, and distribution of pharmaceutical, biological, and other products used in the fields of human and veterinary medicine. It also provides related consultancy services. The company was founded by Ulrich Kessler and Paramjit Singh Arora on September 20, 2013 and is headquartered in Zurich, Switzerland. | Biotechnology | Chairman | |
SWIPRA - Swiss Proxy Advisor
SWIPRA - Swiss Proxy Advisor Investment ManagersFinance SWIPRA - Swiss Proxy Advisor operates as an independent proxy advisor. It provides analyses and voting recommendations regarding Swiss issuers that are listed on the SIX Swiss Exchange. The company is headquartered in Zurich, Switzerland. | Investment Managers | Chief Executive Officer | |
Rennverein Zürich | Corporate Officer/Principal | ||
PharmaBiome AG
PharmaBiome AG Miscellaneous Commercial ServicesCommercial Services PharmaBiome AG specializes in isolation, characterization, and technology of novel intestinal microbes. It develops and produces microbiome therapies to treat intestinal diseases. The company was founded by Tomas de Wouters and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Chairman | |
Lemongrass Communications AG
Lemongrass Communications AG Miscellaneous Commercial ServicesCommercial Services Lemongrass Communications AG engages in the provision of strategic communications solutions. It specializes in reputation management, board and executive consulting, special situations, corporate branding and positioning, as well as sponsorship and event communications. The company was founded by Karin Rhomberg and Cornelia Schmid on September 21, 2005 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Chairman | |
Rigi Healthcare AG | Director/Board Member | ||
Viopas Venture Consulting GmbH
Viopas Venture Consulting GmbH Investment ManagersFinance Viopas Venture Consulting GmbH (Viopas Venture Consulting) is a venture capital firm founded in 2016 by Simon Jules Nebel. The firm is headquartered in Zürich, Switzerland. | Investment Managers | Corporate Officer/Principal | |
SWIPRA Services AG | Chief Executive Officer | ||
North East Finance (Subco) Ltd.
North East Finance (Subco) Ltd. Financial ConglomeratesFinance Part of NF Holdings Ltd., North East Finance (Subco) Ltd. provides investment services. The company is based in Newcastle-upon-Tyne, UK. | Financial Conglomerates | Director/Board Member | |
Visgenx, Inc.
Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
TACALYX GmbH
TACALYX GmbH Miscellaneous Commercial ServicesCommercial Services TACALYX GmbH engages in the discovery and development of Tumor Associated Carbohydrate Antigenantibodies to treat cancer. The company was founded by Peter Sondermann, Peter H. Seeberger, and Oren Moscovitz and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Chairman | |
CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member | |
GAIN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ONCONETIX, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
Zwitserland | 23 |
Duitsland | 11 |
Verenigde Staten | 7 |
Verenigd Koninkrijk | 5 |
Nederland | 4 |
Sectoraal
Health Technology | 21 |
Finance | 10 |
Consumer Services | 7 |
Commercial Services | 6 |
Consumer Durables | 2 |
Operationeel
Director/Board Member | 85 |
Corporate Officer/Principal | 38 |
Chairman | 24 |
Independent Dir/Board Member | 16 |
Chief Executive Officer | 12 |
Sterkste connecties
Insiders | |
---|---|
Hans-Peter Hasler | 28 |
Michael Lytton | 24 |
Timothy James Rink | 23 |
Bernd Seizinger | 23 |
Klaus Schollmeier | 17 |
Barbara Anna Heller | 17 |
Martin Gertsch | 14 |
Thomas Meier | 9 |
Rudolf Gygax | 9 |
Helmut H. Kessmann | 8 |
Bill Blair | 6 |
Oliver Strub | 4 |
Peter Wolf | 3 |
Günther Metz | 2 |
Rudolf Hausmann | 2 |
- Beurs
- Insiders
- Mark C. Clement
- Bedrijfsconnecties